Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank
Xiaofei Wang, Ziyan Shi, Yuhan Qiu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

UK Biobank—A Unique Resource for Discovery and Translation Research on Genetics and Neurologic Disease
Hannah Taylor, Melissa Lewins, M. George B. Foody, et al.
Neurology Genetics (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 1
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Plasma IL-6 levels and their association with brain health and dementia risk: A population-based cohort study
Zhengyang Zhao, Jiashuo Zhang, Yulu Wu, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 430-438
Open Access | Times Cited: 4
Spatiotemporal Dysregulation of Neuron–Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer’s Disease
M. Di Ianni, Miriam Corraliza-Gómez, Tiago Costa-Coelho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9475-9475
Open Access | Times Cited: 4
Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review
Mo‐Kyung Sin, Jeffrey L. Dage, Kwangsik Nho, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1070-1070
Open Access
Astrocyte and oligodendrocyte pathology in Alzheimer's disease
Rania Ziar, Paul J. Tesar, Benjamin L.L. Clayton
Neurotherapeutics (2025), pp. e00540-e00540
Open Access
Neuroinflammatory fluid biomarkers in patients with Alzheimer’s disease: a systematic literature review
Michael T. Heneka, Serge Gauthier, Sagar Anil Chandekar, et al.
Molecular Psychiatry (2025)
Open Access
Utilizing Nanomaterials in Microfluidic Devices for Disease Detection and Treatment
Zhenyu Tian, Yatian Fu, Zhaolong Dang, et al.
Nanomaterials (2025) Vol. 15, Iss. 6, pp. 434-434
Open Access
Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review
Huijun Li, Zhe Wang
NeuroMarkers. (2025) Vol. 2, Iss. 2, pp. 100078-100078
Open Access
Assessing diagnostic performance of plasma biomarkers in Alzheimer’s disease versus cognitively unimpaired individuals: P-tau217 emerges as the optimal marker in Chinese cohorts
Shinan Wang, Dequan Liu, Haiyan Li, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
Mrinmay Dhauria, Ritwick Mondal, Shramana Deb, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10911-10911
Open Access | Times Cited: 4
Blood tests could soon predict your risk of Alzheimer’s
Alison Abbott
Nature (2024) Vol. 632, Iss. 8024, pp. 243-245
Closed Access | Times Cited: 3
Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review
Ioannis Liampas, Panagiota Kyriakoulopoulou, Vasiliki Karakoida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11838-11838
Open Access | Times Cited: 2
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Jared Phillips, Rebecca L. Winfree, Mabel Seto, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 1
Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer’s Disease and Frontotemporal Dementia: A Pilot Study
Claudia Saraceno, Carlo Cervellati, Alessandro Trentini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8354-8354
Open Access | Times Cited: 1
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature
Tina Milos, Barbara Vuić, N. Balic, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-17
Closed Access | Times Cited: 1
Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysis
Matthew Kang, Jasleen Grewal, Dhamidhu Eratne, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 1091-1102
Open Access | Times Cited: 1
Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimers Disease in Kinshasa, Democratic Republic of Congo
Jean Ikanga, Kharine Jean, Priscilla Medina, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Serum Glial Fibrillary Acidic Protein (GFAP) as a Potential Biomarker for Monitoring Postoperative Complications in Deep Brain Stimulation Surgery
Anika Frank, Jonas Arjomand, Jonas Bendig, et al.
Research Square (Research Square) (2024)
Open Access
Current status of fluid biomarkers for early Alzheimer's disease and FDA regulation implications
Angelo Jamerlan, Seong Soo A. An, John Hulme
Journal of the Neurological Sciences (2024) Vol. 467, pp. 123325-123325
Closed Access
Assessing Diagnostic Performance of Plasma Biomarkers in Alzheimer's Disease: P-tau217 Emerges as the Optimal Marker in Chinese Cohorts
Shinan Wang, Dequan Liu, Haiyan Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top